Laparoscopic and partial nephrectomy
- PMID: 15448025
- DOI: 10.1158/1078-0432.CCR-050003
Laparoscopic and partial nephrectomy
Abstract
Radical nephrectomy is the gold standard curative operation for patients with localized renal cell carcinoma (RCC). Since its introduction in 1990, laparoscopic radical nephrectomy is being increasingly done at numerous institutions worldwide. In the hands of experienced laparoscopic urological surgeons and with adherence to established principles of open radical nephrectomy, laparoscopic radical nephrectomy is now a standard of care for patients with T1-3a N0 M0 RCC. Intermediate-term outcome data indicate equivalent cancer-free survival to open radical nephrectomy in such cases. Nephron-sparing surgery (NSS) is now an established approach for patients with localized RCC when there is a clinically relevant need to preserve renal function. NSS is also indicated in patients with a single, small, unilateral, localized RCC when the opposite kidney is completely normal. The technical success rate with NSS for RCC is excellent, and long-term patient survival free of cancer is comparable with that obtained after radical nephrectomy. We recently reviewed the results of NSS in 107 patients with localized sporadic RCC treated at the Cleveland Clinic before 1988 who were followed up for a minimum of 10 years. Long-term preservation of renal function was achieved in 93% of patients, and the 10-year cancer specific survival rate was 73%. Although open surgical partial nephrectomy remains the gold standard for nephron-sparing treatment of RCC, laparoscopic partial nephrectomy is now available in selected cases. The optimal indications for laparoscopic NSS are in patients with a relatively small and peripheral renal tumor. In such cases, laparoscopic NSS is proving to be an effective, minimally invasive therapeutic approach with respect to renal functional outcome, with additional advantages of reduced postoperative narcotic use, earlier hospital discharge, and a faster convalescence. The laparoscopic approach is associated with longer warm renal ischemia time, more major intraoperative complications, and more postoperative urological complications. Continued efforts are required to develop laparoscopic renal hypothermia techniques and to facilitate intrarenal suturing while minimizing the warm ischemia time.
Similar articles
-
Efficacy and safety of nephron-sparing surgery.Int J Urol. 2010 Apr;17(4):314-26. doi: 10.1111/j.1442-2042.2010.02482.x. Int J Urol. 2010. PMID: 20409229 Review.
-
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.J Urol. 2004 Mar;171(3):1066-70. doi: 10.1097/01.ju.0000113274.40885.db. J Urol. 2004. PMID: 14767272
-
Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.Eur Urol. 2006 Feb;49(2):308-13. doi: 10.1016/j.eururo.2005.10.020. Epub 2005 Dec 9. Eur Urol. 2006. PMID: 16359779
-
Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.Eur Urol. 2009 May;55(5):1171-8. doi: 10.1016/j.eururo.2009.01.042. Epub 2009 Feb 20. Eur Urol. 2009. PMID: 19232819
-
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.Eur Urol. 2010 Feb;57(2):223-32. doi: 10.1016/j.eururo.2009.10.023. Epub 2009 Oct 20. Eur Urol. 2010. PMID: 19853989 Review.
Cited by
-
Clinical outcomes of laparo-endoscopic single-site surgery radical nephrectomy.World J Urol. 2012 Oct;30(5):589-96. doi: 10.1007/s00345-011-0765-1. Epub 2011 Sep 30. World J Urol. 2012. PMID: 21960202 Review.
-
Diffusion of surgical innovation among patients with kidney cancer.Cancer. 2008 Apr 15;112(8):1708-17. doi: 10.1002/cncr.23372. Cancer. 2008. PMID: 18330868 Free PMC article.
-
Nephrectomy and IVC thrombectomy in renal cancer: a narrative review.Clin Transl Oncol. 2024 Mar;26(3):574-583. doi: 10.1007/s12094-023-03302-6. Epub 2023 Aug 11. Clin Transl Oncol. 2024. PMID: 37568007 Review.
-
Early renal cell cancer.Int J Clin Oncol. 2006 Feb;11(1):22-7. doi: 10.1007/s10147-005-0551-4. Int J Clin Oncol. 2006. PMID: 16508725 Review.
-
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.Urol Oncol. 2021 Sep;39(9):548-560. doi: 10.1016/j.urolonc.2021.04.038. Epub 2021 Jun 4. Urol Oncol. 2021. PMID: 34092483 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical